NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Barrett Esophagus



Scientists at University of Otago, Medical Department report research in barrett esophagus



September 30th, 2008

"The incidence of esophageal adenocarcinoma has increased significantly. Barrett's esophagus (BE), a known precursor, has a high prevalence but only few patients with this condition progress to malignancy - surveillance and screening programs are controversial and lack proven efficacy," researchers in Dunedin, New Zealand report.

"This retrospective analysis reviews the 13-year outcome for patients entered into a surveillance program. Data from patients with histologically proven Barrett's esophagus (1992-2003) that participated in a surveillance program were identified and analyzed retrospectively until 2005. 404/536 patients had Barrett's esophagus confirmed...


Source: Cancer Weekly (2008-09-30)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login